USPTO serial 79236421
DIABILIVE
Reviewed by CopyMark Law Group
Reg. 5688304Status 709
- Filing date
- Status date
- Registration date
- Mar 5, 2019
- Examiner
- MICKLEBURGH, LINDA BOHANNON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with DIABILIVE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
F-33650 Martillac, FR
F-33650 Martillac, FR
F-33650 Martillac, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Judith A. Keene
JUDITH A. KEENE HOLZER PATEL DRENNAN216 16TH ST # 1350DENVER, CO 80202UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Scientific, photographic, optical, weighing, and measuring apparatus and instruments, namely, smart watches, weighing scales, thermometers, global positioning system (GPS) apparatus, hydrometers, and height gauges to test and manage blood glucose, carbohydrate intake, calorie intake, and physical activity, and to calculate and manage insulin dosage, and to provide related reports and alerts; apparatus for recording, transmission, or reproduction of sound or images; magnetic recording media, sound recording disks, compact disks, dvds, and other digital recording media, namely, USB keys containing medical data and health reports; data processing apparatus; computers; software to test and manage blood glucose, carbohydrate intake, calorie intake, and physical activity, and to calculate and manage insulin dosage, and to provide related reports and alerts; computer programs, namely, software to test and manage blood glucose, carbohydrate intake, calorie intake, and physical activity, and to calculate insulin dosage, and to provide related reports and alerts; computer application software for mobile phones to test and manage blood glucose, carbohydrate intake, calorie intake, and physical activity, and to calculate and manage insulin dosage, and to provide related reports and alerts; downloadable mobile applications for portable computer devices, namely, software to test and manage blood glucose, carbohydrate intake, calorie intake, and physical activity, and to calculate and manage insulin dosage, and to provide related reports and alerts; downloadable software for data management namely, software to manage data derived from testing and managing blood glucose, carbohydrate intake, calorie intake, calculating and managing insulin dosage, physical activity levels, and related reports; electronic databases to maintain information regarding blood glucose, carbohydrate intake, calorie intake, and physical activity, and to calculate and manage insulin dosage, all recorded on computer media; downloadable image files containing imagery relating to blood glucose, carbohydrate intake, calorie intake, and physical activity; downloadable cloud software, namely, software to test and manage blood glucose, carbohydrate intake, calorie intake, and physical activity, and to calculate and manage insulin dosage, and to provide related reports and alerts; cloud network servers | SECTION 71 - CANCELLED | — |
| 010 | Medical, surgical, dental, and veterinary apparatus and instruments, namely, glucometers, blood pressure monitors, oximeters, and thermometers to test and manage blood glucose, carbohydrate intake, calorie intake, and physical activity, and to calculate and manage insulin dosage, and to provide related reports and alerts; electronic apparatus for medical use, namely, glucometers, blood pressure monitors, oximeters, and thermometers to test and manage blood glucose, carbohydrate intake, calorie intake, and physical activity, and to calculate and manage insulin dosage, and to provide related reports and alerts; diagnostic apparatus for medical use, namely, glucometers, blood pressure monitors, oximeters, and thermometers; analysis apparatus for medical use, namely, glucometers, blood pressure monitors, oximeters, and thermometers; automatic analyzers for medical diagnosis, namely, glucometers, blood pressure monitors, oximeters, and thermometers; blood glucose monitors; blood testing apparatus for medical use | SECTION 71 - CANCELLED | — |
| 038 | Telecommunications, namely, video conferencing; provision of access to databases; provision of access to online databases; communication by electronic computer terminals; rental of message sending apparatus, namely, smartphones, medical data readers, and personal computers; transmission of digital files; computer-aided transmission of messages and images; provision of access to platforms and portals on the Internet relating to health, medicine, and wellness | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services, namely, scientific research in the field of testing and managing blood glucose, carbohydrate intake, calorie intake, calculating and managing insulin dosage, and physical activity levels, and providing related reports and alerts; design and development of computers and software; development of computer hardware; design and development of software in the field of mobile applications; information technology (IT) consultancy; engineering in the field of medical equipment; software as a service (SAAS) services featuring software for testing and managing blood glucose, carbohydrate intake, and calorie intake, calculating and managing insulin dosage, and physical activity levels, and providing related reports and alerts; research and development of new products; programming of computers for others; software consultancy; design, development, programming, and implementation of software; rental of software; maintenance of software; cloud hosting provider services; electronic data storage; hosting the websites of others on a computer server for a global computer network; providing search engines containing medical information | SECTION 71 - CANCELLED | — |
| 044 | Medical services; medical testing for diagnostic or treatment purposes in the field of diabetes, hypoglycemia, and hyperglycemia; providing an Internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed information to the website that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions; home health care services; advisory services relating to health and medical care; providing medical and health information and providing healthcare consulting; information relating to health, namely, testing and managing blood glucose, carbohydrate intake, calorie intake, calculating and managing insulin dosage, physical activity levels, and related reports; medical analysis services in the field of diabetes, hypoglycemia, and hyperglycemia; medical assistance | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MirambeauAppCare
- Other trademarks owned by MirambeauAppCare
- Other trademarks owned by MirambeauAppCare
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 038
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named DIABILIVE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 19, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 19, 2025 | C71T | CANCELLED SECTION 71 | — |
| Mar 5, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 16, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 19, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 28, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 28, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 5, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 5, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 18, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 18, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 15, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 28, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 28, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 28, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 15, 2018 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 12, 2018 | ALIE | ASSIGNED TO LIE | — |
| Oct 30, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 30, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 30, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 30, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 30, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 12, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 11, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 11, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 31, 2018 | RFNP | REFUSAL PROCESSED BY IB | — |
| Aug 16, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 16, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 3, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 2, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 2, 2018 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Jul 18, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 18, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 17, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 15, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 14, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 12, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |